Champions Bayer Leverkusen cruised to a 4-1 victory at Hoffenheim on Saturday thanks to a dazzling performance by Victor Boniface that included two goals and an assist. Leverkusen's unbeaten ...

Match ends, Borussia Mönchengladbach 2, Bayer 04 Leverkusen 3. Goal! Borussia Mönchengladbach 2, Bayer 04 Leverkusen 3. Florian Wirtz (Bayer 04 Leverkusen) right footed shot from very close ...

On Tuesday, Gline obliged. Roivant has acquired from Bayer, the German pharma company, an experimental drug called mosliciguat that will be developed as a treatment for certain types of pulmonary ...

Bayer and NextRNA Therapeutics have announced a collaboration and license agreement worth $547m to develop small molecule therapeutics against a new class of targets in oncology. The partnership will ...

Bayer said an appeals court ruled in favor of its Monsanto unit in a case alleging the agricultural-chemical maker should have warned users about the cancer risk of its Roundup weedkiller.

At its recent summit, AWS listed Bayer Crop Science among its enterprise customers pushing the envelope on generative AI innovation, alongside Exscientia’s advanced drug discovery platform and ...

Bayer is targeting a broader use of Nubeqa in metastatic hormone-sensitive prostate (mHSPC) cancer with a combination free of chemotherapy. Bayer plans to seek the FDA’s blessing for Nubeqa plus ...

Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA ...

Matt Gline is back with a new ‘vant’ company, after the Roivant Sciences CEO paid Bayer $14 million upfront for the rights to ...

Bayer suspended the phase 3 trial for its factor XIa inhibitor asundexian late last year after the drug showed “inferior efficacy” at preventing strokes in patients with atrial fibrillation ...

Because of this, the brand's parent company, Bayer, has seen its fair share of lawsuits holding Bayer liable for failing to disclose the product's dangers. Now, Bayer has turned to both state ...

In 2005, the same year, the US FDA approved Nexavar (sorafenib), a drug for the treatment of advanced renal cell carcinoma, jointly developed by Bayer HealthCare and Onyx Pharmaceuticals.